Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Cytological Diagnosis of an Uncommon High Grade Malignant Thyroid Tumour: A Case Report.

Nagpal R, Kaushal M, Kumar S.

J Clin Diagn Res. 2017 Jul;11(7):ED03-ED05. doi: 10.7860/JCDR/2017/28531.10132. Epub 2017 Jul 1.

2.
3.

Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling.

Zhang K, Liu X, Hao F, Dong A, Chen D.

Am J Transl Res. 2016 May 15;8(5):2196-209. eCollection 2016.

4.

Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.

Zimmermann MB, Galetti V.

Thyroid Res. 2015 Jun 18;8:8. doi: 10.1186/s13044-015-0020-8. eCollection 2015.

5.

Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.

Patel PN, Yu XM, Jaskula-Sztul R, Chen H.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S497-504. doi: 10.1245/s10434-013-3459-7. Epub 2014 Jan 14.

6.

The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview.

Treglia G, Annunziata S, Muoio B, Salvatori M, Ceriani L, Giovanella L.

Int J Endocrinol. 2013;2013:856189. doi: 10.1155/2013/856189. Epub 2013 Apr 9.

7.

CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.

Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM, Tsai YF, Ho JH, Lee CH, Lee OK.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):61-71. doi: 10.1007/s00259-012-2242-5. Epub 2012 Oct 19.

8.

Clinical and economic outcomes of thyroid surgery in elderly patients: a systematic review.

Sullivan MC, Roman SA, Sosa JA.

J Thyroid Res. 2012;2012:615846. doi: 10.1155/2012/615846. Epub 2012 Jun 21.

9.

Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer.

Tran Cao HS, Kaushal S, Snyder CS, Ongkeko WM, Hoffman RM, Bouvet M.

Anticancer Res. 2010 Nov;30(11):4415-22.

10.

Advances in cellular therapy for the treatment of thyroid cancer.

Papewalis C, Ehlers M, Schott M.

J Oncol. 2010;2010:179491. doi: 10.1155/2010/179491. Epub 2010 Jun 29.

11.

Thyroid cancer: current molecular perspectives.

Giusti F, Falchetti A, Franceschelli F, Marini F, Tanini A, Brandi ML.

J Oncol. 2010;2010:351679. doi: 10.1155/2010/351679. Epub 2010 Mar 29.

12.

Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.

Alfano RW, Leppla SH, Liu S, Bugge TH, Ortiz JM, Lairmore TC, Duesbery NS, Mitchell IC, Nwariaku F, Frankel AE.

Mol Cancer Ther. 2010 Jan;9(1):190-201. doi: 10.1158/1535-7163.MCT-09-0694. Epub 2010 Jan 6.

Supplemental Content

Support Center